XBI — State Street SPDR S&P Biotech ETF price, holdings and performance
State Street SPDR S&P Biotech ETFState Street SPDR S&P Biotech ETF (AMEX: XBI) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.
| Category | - | Asset Type | Equity | Tags | healthcare | Return% 1Y | 85.10% | Total Holdings | 155 | Perf Week | 7.05% |
| Sponsor | SPDR | ETF Type | Tags | sector | Return% 3Y | 24.86% | AUM | $10.16B | Perf Month | -4.21% | |
| Fund Family | Bond Type | Tags | - | Return% 5Y | 5.00% | NAV/sh | Perf Quarter | 17.74% | |||
| Index | - | Average Maturity | Tags | - | Return% 10Y | 52W High | 166.40 -5.03% | Perf Half Y | 30.36% | ||
| Index Weighting | Commodity Type | Tags | - | Return% SI | 52W Low | 84.88 86.19% | Perf YTD | 29.07% | |||
| Active/Passive | Quant Type | Tags | - | Flows% 1M | 0.00% | Volatility | 2.52% 2.80% | Perf Year | 82.71% | ||
| Dividend TTM | 0.57 (0.36%) | ESG Type | Tags | - | Flows% 3M | -15.82% | ATR (14) | 4.25 | Perf 3Y | 91.77% | |
| Dividend Ex-Date | Jun 22, 2026 | Dividend Type | Sector/Theme | Flows% YTD | -14.93% | RSI (14) | 60.21 | Perf 5Y | 27.52% | ||
| Dividend Gr. 3/5Y | - | Structure Type | Region | Flows% 1Y | Beta | 0.82 | Perf 10Y | 156.64% | |||
| Expense | 0.35% | Growth/Value | SMA20 | 3.38% | Flows% 3Y | Rel Volume | 0.93 | Prev Close | 157.37 | ||
| Inverse/Leveraged | Market Cap | SMA50 | 6.74% | Flows% 5Y | Avg Volume | 8.98M | Price | 158.03 | |||
| IPO Date | Jan 31, 2006 | Option/Short | Yes / Yes | SMA200 | 20.91% | 52W Range % | 90% | Volume | 8,380,703 | Change | 0.42% |
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.
Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.